Subcutaneous immunotherapy injections for cancer, such as immune checkpoint inhibitors, are an emerging therapy that may replace some traditional intravenous infusions. Common side effects include ...
Older patients receiving immune checkpoint inhibitors for early-stage breast cancer may have increased risk of high-grade immune-related side effects. The study found 72.6% of patients experienced any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results